Details for New Drug Application (NDA): 201692
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER is clindamycin phosphate. There are fifty-five drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.
Summary for 201692
Tradename: | CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER |
Applicant: | Sandoz Inc |
Ingredient: | clindamycin phosphate |
Patents: | 0 |
Pharmacology for NDA: 201692
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 201692
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER | clindamycin phosphate | INJECTABLE;INJECTION | 201692 | ANDA | Sandoz Inc | 0781-3288 | 0781-3288-09 | 24 BAG in 1 CARTON (0781-3288-09) / 50 mL in 1 BAG (0781-3288-91) |
CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER | clindamycin phosphate | INJECTABLE;INJECTION | 201692 | ANDA | Sandoz Inc | 0781-3289 | 0781-3289-09 | 24 BAG in 1 CARTON (0781-3289-09) / 50 mL in 1 BAG (0781-3289-91) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 6MG BASE/ML | ||||
Approval Date: | May 31, 2012 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 12MG BASE/ML | ||||
Approval Date: | May 31, 2012 | TE: | AP | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 18MG BASE/ML | ||||
Approval Date: | May 31, 2012 | TE: | AP | RLD: | No |
Complete Access Available with Subscription